more general categories |
information about this item |
|
04. Bioactive Capabilities of Specific Chemicals |
 |
 |
|
04. Bioactive Capabilities of Specific Chemicals |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
 |
08. Chemical Category |
 |
 |
|
08. Chemical Category |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifamycin O [CHEBI:16324] (1) |
|
 |
ChEBI Compound Accession Identifier: |
[CHEBI:16324] |
ChEBI Compound Description: |
null |
ChEBI Compound Identification Number: |
16324 |
ChEBI InChI Value: |
InChI=1S/C39H47NO14/c1-17-11-10-12-18(2)37(48)40-24-15-39(51-16-26(42)53-39)29-27(33(24)46)32(45)22(6)35-28(29)36(47)38(8,54-35)50-14-13-25(49-9)19(3)34(52-23(7)41)21(5)31(44)20(4)30(17)43/h10-15,17,19-21,25,30-31,34,43-45H,16H2,1-9H3,(H,40,48)/b11-10+,14-13+,18-12-/t17-,19+,20+,21+,25-,30-,31+,34+,38-,39?/m0/s1 |
ChEBI InChIKey Value: |
RAFHKEAPVIWLJC-KQOHHTLASA-N |
ChEBI Compound Name: |
rifamycin O |
ChEBI SMILES Value: |
CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=CC1(OCC(=O)O1)c4c3C2=O |
ChEBI Substance ID: |
8143431 |
ChEBI URL: |
ChEBI:16324 |
ChemSpider ID: |
NS |
Ontomatica Chemical Accession Key (OnChAKey): |
RAFHKEAPVIWLJC_KQOHHTLASA_N_000_000000 |
PubChem Compound ID: |
5280468 |